ETO Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ETO Antibodies for research focused on understanding ETO protein mechanisms. ETO Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The ETO protein, also known as the Eight-Twenty-One protein, plays a critical role in regulating gene expression and is involved in hematopoiesis and the development of certain cancers. As a transcriptional co-repressor, ETO significantly influences oncogenesis and cellular differentiation processes. Research focusing on ETO mechanisms can reveal important insights into therapeutic strategies for diseases associated with its dysregulation. Scientists worldwide utilize ETO monoclonal antibodies to advance their understanding of cellular processes and disease mechanisms. Ongoing studies of ETO continue to uncover new aspects of gene regulation and cancer development. Research supported by Santa Cruz Biotechnology monoclonal antibodies contributes to advancing scientific knowledge and potential therapeutic developments in the field of cancer biology.